1. Home
  2. FBIOP vs ICUCW Comparison

FBIOP vs ICUCW Comparison

Compare FBIOP & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • ICUCW
  • Stock Information
  • Founded
  • FBIOP N/A
  • ICUCW N/A
  • Country
  • FBIOP United States
  • ICUCW United States
  • Employees
  • FBIOP 186
  • ICUCW 12
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • FBIOP Health Care
  • ICUCW Health Care
  • Exchange
  • FBIOP Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • FBIOP N/A
  • ICUCW N/A
  • IPO Year
  • FBIOP N/A
  • ICUCW 2021
  • Fundamental
  • Price
  • FBIOP $6.37
  • ICUCW $0.03
  • Analyst Decision
  • FBIOP
  • ICUCW
  • Analyst Count
  • FBIOP 0
  • ICUCW 0
  • Target Price
  • FBIOP N/A
  • ICUCW N/A
  • AVG Volume (30 Days)
  • FBIOP N/A
  • ICUCW N/A
  • Earning Date
  • FBIOP N/A
  • ICUCW N/A
  • Dividend Yield
  • FBIOP N/A
  • ICUCW N/A
  • EPS Growth
  • FBIOP N/A
  • ICUCW N/A
  • EPS
  • FBIOP N/A
  • ICUCW N/A
  • Revenue
  • FBIOP N/A
  • ICUCW N/A
  • Revenue This Year
  • FBIOP N/A
  • ICUCW N/A
  • Revenue Next Year
  • FBIOP N/A
  • ICUCW N/A
  • P/E Ratio
  • FBIOP N/A
  • ICUCW N/A
  • Revenue Growth
  • FBIOP N/A
  • ICUCW N/A
  • 52 Week Low
  • FBIOP N/A
  • ICUCW N/A
  • 52 Week High
  • FBIOP N/A
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 51.85
  • ICUCW N/A
  • Support Level
  • FBIOP $6.40
  • ICUCW N/A
  • Resistance Level
  • FBIOP $7.10
  • ICUCW N/A
  • Average True Range (ATR)
  • FBIOP 0.72
  • ICUCW 0.00
  • MACD
  • FBIOP -0.01
  • ICUCW 0.00
  • Stochastic Oscillator
  • FBIOP 50.66
  • ICUCW 0.00

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: